Withdrawals due to adverse events · Patients with osteoarthritis of the knee or hip
Tramadol alone probably leads to higher number of participants who withdrew due to adverse events compared with placebo (moderate certainty).
1 finding from 1 review
Intervention not reported
Risk of adverse events (until time of hospital discharge) · individuals with infant botulism
The intervention showed no clear difference in risk of adverse events (until time of hospital discharge) (moderate certainty).
1 finding from 1 review
Suicide · people in the prodromal stage of psychosis
It is very uncertain whether group C other: family treatment changes adverse events: suicide (events) Long‐term (by 24 months) compared with enhanced care (very low certainty).
1 finding from 1 review
Non‐serious adverse events: serum transaminases elevation · primary hepatocellular carcinoma
It is very uncertain whether TACE followed by 3‐DCRT changes non‐serious adverse events: serum transaminases elevation compared with TACE (very low certainty).
1 finding from 1 review
Adverse effects requiring withdrawal/discontinuation of study medication · People on continuous VKA treatment undergoing minor oral surgery or dental extractions (eligibility included DOACs and all ages; all four…
Antifibrinolytic therapy - locally-applied tranexamic acid (TXA)… showed no clear difference in side effects or other adverse events requiring withdrawal compared with placebo (placebo solution/mouthwash) (moderate certainty).
1 finding from 1 review
Adverse events including treatment‐related adverse events · pregnant women with gonorrhoea infection
1 finding from 1 review
Adverse events including treatment‐related adverse events · pregnant women with gonorrhoea infection
It is very uncertain whether intramuscular ceftriaxone changes adverse events including treatment‐related adverse events compared with oral amoxicillin plus oral probenecid (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Paget's disease of bone
Bisphosphonates showed no clear difference in number of participants who withdrew due to adverse events compared with placebo (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events ‐ Change of/or withdrawal from treatment ( · people with hepatic encephalopathy
It is very uncertain whether the intervention changes adverse events ‐ Change of/or withdrawal from treatment ( (very low certainty).
1 finding from 1 review
Intervention not reported
Adverse events ‐ Change of/or withdrawal from treatment ( · people with hepatic encephalopathy
It is very uncertain whether the intervention changes adverse events ‐ Change of/or withdrawal from treatment ( (very low certainty).
1 finding from 1 review
Intervention not reported
Serious adverse events Duration of trials: 12 to 20 weeks · adults and adolescents with persistent asthma
The intervention probably leads to higher serious adverse events Duration of trials: 12 to 20 weeks (moderate certainty).
1 finding from 1 review
Adverse events: dysphagia № of participants: 249 (3 RCTs) · adults with cervical dystonia
Botulinum toxin type A showed no clear difference in adverse events: dysphagia № of participants: 249 (3 RCTs) compared with botulinum toxin type B (low certainty).
1 finding from 1 review
RR 2.89 [0.8, 10.41]
Studies not reported
Low
Adverse events ‐ cardiac toxicity Diagnosed by clinicians · patients with oesophageal cancer
Active cancer therapy combined with TCM showed no clear difference in adverse events ‐ cardiac toxicity Diagnosed by clinicians compared with active cancer therapy (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events: a. mild hypoglycaemia (% of participants)
1 finding from 1 review
Adverse events Number of participants with adverse events · general participants
1 finding from 1 review
Adverse events Grade 3 oesophagitis, diarrhoea and nausea · adults with metastatic extradural spinal cord compression (poor prognosis with visceral metastasis, and no spinal instability or bony…
Single‐fraction radiotherapy (8 Gy) showed no clear difference in adverse events Grade 3 oesophagitis, diarrhoea and nausea compared with short‐course radiotherapy (16 Gy (moderate certainty).
1 finding from 1 review
Adverse events: number of treatment‐related adverse events · children with cystic fibrosis
1 finding from 1 review
Adverse events: number of treatment‐related adverse events · adults and children with cystic fibrosis
1 finding from 1 review
Adverse events: number of treatment related adverse events · adolescents and adults with cystic fibrosis
1 finding from 1 review
Adverse events: number of treatment related adverse events · adults and children with cystic fibrosis and a positive microbiological isolate of P aeruginosa from a respiratory tract specimen
Summary of findings: colistimethate dry powder for inhalation… may leads to higher adverse events: number of treatment related adverse events compared with tobramycin (low certainty).
1 finding from 1 review